IHS Chemical Week

EnviroTech :: Biotech

Nitto Denko Buys Avecia Biotechnology

10:41 AM MST | February 4, 2011 | Alex Scott

Nitto Denko (Osaka, Japan), a diversified materials producer, says it has acquired Avecia Biotechnology Inc. (Milford, MA), a producer of DNA - and RNA –based medicines. Financial terms were not disclosed.   Avecia provides Good Manufacturing Practices (cGMP) services including the development of analytical methods, process validation, stability studies, quality control, and regulatory support around the production of DNA and RNA medicines.   Nitto Denko says the acquisition will enhance its activities in the nucleic medicines through a series of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa